Nasdaq • RXRX • US75629V1044
As of Oct 29, 2026, ORTEX estimated 26.6% of free float sold short, 5.2 days to cover, cost to borrow 0.75%. Sign up for live short interest data.
This page tracks how heavily Recursion Pharmaceuticals (Nasdaq:RXRX) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Recursion Pharmaceuticals (Nasdaq: RXRX) has a market capitalization of $1.99B. Last close $3.19 (as of 2026-11-16); 52-week range $2.77 to $5.24. ORTEX data as of 2026-10-29: short interest was 26.61% of free float, 5.2 days to cover and the average cost to borrow was 0.75%. Sign up for live short interest data.
